This is a serious condition affecting the jawbone. It happens to some people who take long-term bisphosphonate medications, which are often used to treat osteoporosis. The jawbone can become damaged and die, leading to infection and pain. It's important to talk to your doctor if you are taking these medications and experience any jaw pain or swelling.
Every report comes from a Lived member, sent anonymously.
Have you tried Chlorhexidine for Bisphosphonate-Associated Osteonecrosis of the Jaw?
Bisphosphonate-associated osteonecrosis of the jaw is an uncommon condition in which an area of jawbone dies and becomes exposed in the mouth, in someone who takes or has taken a bisphosphonate. Bisphosphonates are medicines that slow the breakdown of bone. They include alendronate (Fosamax) tablets and zoledronic acid infusions, used to prevent fractures in osteoporosis and to protect bones affected by cancer. The usual sign is a patch of bare bone showing through the gum, often where a tooth was removed and the socket never healed. Some people have no pain at first. Others develop jaw pain, swelling, infection or a loose tooth. Specialists now often use the broader name medication-related osteonecrosis of the jaw (MRONJ), because other bone medicines, especially denosumab (Prolia), can cause the same problem.
Bisphosphonates work by quieting the cells that break down and remodel bone. That protects the skeleton, but it may also slow the jaw's ability to repair itself after injury or infection. The jaw is especially exposed to both, since teeth and gums sit directly on the bone. The most common trigger is a tooth extraction or other surgery involving the jawbone, though cases also appear without any obvious cause. Gum disease, infected teeth, poor oral hygiene and ill-fitting dentures add to the risk. So do cancer, chemotherapy, corticosteroids (anti-inflammatory steroid medicines) and certain cancer drugs that block blood vessel growth. Risk also rises the longer the medicine has been taken. The dose and reason for treatment matter most. With the doses used for osteoporosis, the risk is very low, roughly 2 to 5 cases per 10,000 people, which is close to the rate seen in people taking a placebo. With the much higher, more frequent doses used for cancer that has spread to bone, the risk is considerably higher, generally under 5 in 100.
Diagnosis is mainly clinical. A dentist, oral surgeon or physician makes it when three things are true: the person has taken a bisphosphonate or similar bone medicine, there is exposed jawbone (or bone that can be reached through a small draining opening in the gum or skin) that has lasted more than eight weeks, and the jaw has never received radiation treatment or been affected by cancer spread. The eight-week window separates this condition from ordinary slow healing after dental work. Dental x-rays or a CT (computed tomography) scan show how far the damaged bone extends and whether loose fragments of dead bone are forming. Clinicians also rule out look-alikes, such as a dry socket after an extraction, gum disease, a tooth abscess, sinus infection or, in people with cancer, a tumor in the jaw. Sometimes symptoms and x-ray changes appear before any bone is exposed; specialists watch this early stage closely because it can progress. The findings are usually described by stage: exposed bone without symptoms (stage 1), exposed bone with pain or infection (stage 2), and more extensive disease reaching beyond the tooth-bearing part of the jaw or causing a fracture or opening through the skin or into the sinus (stage 3).
Prevention is the most effective approach. Before starting a bisphosphonate, especially for cancer, a dental exam lets any infected or failing teeth be treated or removed first, while the jaw can still heal normally. During treatment, good daily oral hygiene and regular dental checkups reduce the chance that an extraction will be needed. People receiving cancer doses are usually advised to avoid jawbone surgery and dental implants if possible. For people taking osteoporosis doses, routine dental care, including extractions when needed, generally goes ahead. Whether to pause the medicine before dental surgery is unsettled. Expert groups disagree, and good evidence that a pause prevents the condition is lacking. For osteoporosis, the protection against fractures generally outweighs the small risk to the jaw, so a decision to stop belongs with the prescriber, not the patient alone. Denosumab is a special case: stopping it can cause a rebound in bone loss and multiple spine fractures, so any pause needs careful timing. Once the condition develops, care is usually led by an oral and maxillofacial surgeon. Early stages are often managed with antiseptic mouth rinses such as chlorhexidine, careful cleaning, pain control and antibiotics when infection appears. Loose pieces of dead bone may separate and be removed, which often lets the area heal. When disease persists, progresses or is more extensive, surgery to remove the dead bone back to healthy, bleeding bone has high reported success. Hyperbaric oxygen and other add-on treatments have little evidence behind them.
Most people, particularly those taking bisphosphonates for osteoporosis, never develop this condition. For those who do, the course varies. A small exposed area may stay stable and painless for a long time, needing only rinses and regular checks, while others heal after a fragment of dead bone comes away or is removed. Infection can cause flare-ups of pain and swelling that settle with antibiotics. Living with it means keeping the area clean, using prescribed rinses, and attending frequent follow-up so the surgeon can watch for spread on examination and x-rays. Dentures may need adjusting so they do not rub on the exposed bone. More extensive surgery can affect chewing and may require reconstruction, which is one reason specialists aim to treat progressing disease early. For people with cancer, the bone medicine often remains important for preventing fractures and bone pain, so the dental and cancer teams usually weigh together whether and when to continue it.
Arrange a dental checkup before starting a bisphosphonate or similar bone medicine, and keep regular dental visits while taking it. Tell every dentist and oral surgeon about the medicine, including past infusions, before any extraction or implant. Contact your dentist or care team promptly if you notice bone showing through the gum, jaw pain, gum or jaw swelling, a tooth that becomes loose without known gum disease, numbness or an unusual feeling in the jaw or lip, or a tooth socket that has not healed several weeks after an extraction. Pus or increasing swelling suggest infection and need timely treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Bisphosphonate-Associated Osteonecrosis of the Jaw is like, what's helped you, or ask the community a question.